The China Post reports that Roche is scouting locations in Singapore for a base to house a $71 million translational research initiative. Neither Roche nor economic development officials are saying much, but they are reportedly looking around Singapore General Hospital and the eye, heart and cancer centers. Big Pharma has been aggressively expanding R&D work in Asia as they maneuver to take advantage of emerging markets while tapping lower cost research personnel. Story